135 related articles for article (PubMed ID: 19798881)
1. Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study.
Pennelli G; Mian C; Pelizzo MR; Naccamulli D; Piotto A; Girelli ME; Mescoli C; Rugge M
Acta Cytol; 2009; 53(5):533-9. PubMed ID: 19798881
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions.
Raggio E; Camandona M; Solerio D; Martino P; Franchello A; Orlandi F; Gasparri G
J Endocrinol Invest; 2010 Jun; 33(6):378-81. PubMed ID: 19625759
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 for indeterminate thyroid cytology.
Al Ghuzlan A; Caillou B; Schlumberger M
Lancet Oncol; 2008 Jun; 9(6):508-10. PubMed ID: 18510984
[No Abstract] [Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
7. The investigation of galectin-3 in diseases of the thyroid gland.
Kovács RB; Földes J; Winkler G; Bodó M; Sápi Z
Eur J Endocrinol; 2003 Nov; 149(5):449-53. PubMed ID: 14585093
[TBL] [Abstract][Full Text] [Related]
8. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
[TBL] [Abstract][Full Text] [Related]
10. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.
Fadda G; Rossi ED; Raffaelli M; Pontecorvi A; Sioletic S; Morassi F; Lombardi CP; Zannoni GF; Rindi G
Eur J Endocrinol; 2011 Sep; 165(3):447-53. PubMed ID: 21724837
[TBL] [Abstract][Full Text] [Related]
11. Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules.
Xiong Y; Li X; Liang L; Li D; Yan L; Li X; Di J; Li T
Virchows Arch; 2021 Nov; 479(5):961-974. PubMed ID: 34308507
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
Kim MJ; Kim HJ; Hong SJ; Shong YK; Gong G
Acta Cytol; 2006; 50(1):28-34. PubMed ID: 16514837
[TBL] [Abstract][Full Text] [Related]
13. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions.
Aiad HA; Kandil MA; Asaad NY; El-Kased AM; El-Goday SF
J Egypt Natl Canc Inst; 2008 Mar; 20(1):36-46. PubMed ID: 19847280
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic pitfall of thyroid fine-needle aspiration induced fibrosis: follicular adenoma mimicking medullary thyroid carcinoma in frozen section.
Moon WS; Kang MJ; Youn HJ; Kim KM
Diagn Pathol; 2021 Mar; 16(1):25. PubMed ID: 33731149
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
Samija I; Mateša N; Lukač J; Kusić Z
Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
[TBL] [Abstract][Full Text] [Related]
18. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
Elsers DA; Hussein MRA; Osman MH; Mohamed GA; Hosny G
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3365-3376. PubMed ID: 34711014
[TBL] [Abstract][Full Text] [Related]
19. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
Lew JI; Snyder RA; Sanchez YM; Solorzano CC
J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
[TBL] [Abstract][Full Text] [Related]
20. Infarction in a thyroid nodule after fine needle aspiration: report of 2 cases with a discussion of the cause of pitfalls in the histopathologic diagnosis of papillary thyroid carcinoma.
Das DK; Janardan C; Pathan SK; George SS; Sheikh ZA
Acta Cytol; 2009; 53(5):571-5. PubMed ID: 19798886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
